ArticleAmerican journal of respiratory and critical care medicine2011
Viruses and acute exacerbations of idiopathic pulmonary fibrosis: rest in peace?
Article in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Cellular Senescence Dysregulates Antiviral Interferon Responses in Idiopathic Pulmonary Fibrosis.Aging cell · 2026Article
- Cellular senescence dysregulates antiviral interferon responses in idiopathic pulmonary fibrosis.bioRxiv : the preprint server for biology · 2026Article
- The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Mediators of inflammation · 2019Article
- Respiratory Viral Infections in Chronic Lung Diseases.Clinics in chest medicine · 2017Review
- Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.Thorax · 2015Article
- Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.Journal of thoracic disease · 2015Review
- Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway.International immunopharmacology · 2012Article
- Update in diffuse parenchymal lung disease 2011.American journal of respiratory and critical care medicine · 2012Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21693713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.